Molecular Drivers of Myelodysplastic Neoplasms (MDS)—Classification and Prognostic Relevance
Myelodysplastic neoplasms (MDS) form a broad spectrum of clonal myeloid malignancies arising from hematopoietic stem cells that are characterized by progressive and refractory cytopenia and morphological dysplasia. Recent advances in unraveling the underlying pathogenesis of MDS have led to the iden...
Main Authors: | Fieke W. Hoff, Yazan F. Madanat |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-02-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/12/4/627 |
Similar Items
-
Management of Patients with Lower-Risk Myelodysplastic Neoplasms (MDS)
by: Josephine Lucero, et al.
Published: (2023-06-01) -
The Secondary Myelodysplastic Neoplasms (MDS) Jigsaw
by: Oriol Calvete, et al.
Published: (2023-02-01) -
The Genetic Landscape of Myelodysplastic Neoplasm Progression to Acute Myeloid Leukemia
by: Claudia Bănescu, et al.
Published: (2023-03-01) -
Clinical, Histopathological and Molecular Spectrum of Cutaneous Lesions in Myelodysplastic Syndrome and Myeloproliferative Neoplasms (MDS/MPN): An Integrative Review
by: Lucía Prieto-Torres, et al.
Published: (2023-12-01) -
Diagnostic and prognostic value of ferroptosis-related genes in patients with Myelodysplastic neoplasms
by: Xiaomei Chen, et al.
Published: (2023-12-01)